6 completed, 1 withdrawn. 2 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Vitreomacular Adhesion: new trials by email Literature Review of Vitreomacular Adhesion trials Research Report on Vitreomacular Adhesion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion Ocriplasmin 0.125 mg in a 0.1 mL volume - Vitreomacular Traction, Vitreomacular Adhesion | Phase 4 | Completed | Alcon Research | 62 | 2015-05-26 | 2018-08-21 |
| Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older Vitreomacular Adhesion | Completed | Nova Southeastern University | 1584 | 2014-05-01 | 2018-03-29 | |
| Assessment of Patients Treated With JETREA® for Vitreomacular Traction Ocriplasmin - Vitreomacular Traction, Vitreomacular Adhesion | Phase 4 | Completed | Alcon Research | 628 | 2014-04-01 | 2016-10-12 |
| Intravitreal Gas for Vitreomacular Adhesion Intravitreal Injection of sulfahexafluoride gas - Vitreomacular Adhesion | Not applicable | Withdrawn | Northern California Retina Vitreous Associates | 2013-11-01 | 2016-02-02 | |
| A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment 36% Resolvine Intravitreal Injection, 9% Resolvine Intravitreal Injection - Vitreomacular Attachment, Vitreomacular Traction | Phase 1 | Completed | Jeffrey S Heier | 21 | 2013-10-01 | 2016-03-31 |
| Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial. Ocriplasmin 125µg, Placebo - Vitreomacular Adhesion | Phase 3 | Completed | ThromboGenics | 326 | 2008-12-01 | 2014-12-17 |
| Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial. 125 µg Ocriplasmin, Placebo - Vitreomacular Adhesion | Phase 3 | Completed | ThromboGenics | 326 | 2008-12-01 | 2014-12-17 |
Epiretinal Membrane (1) · Retinal Perforations (1) · Vitreous Detachment (1)
Eye Diseases (2) · Retinal Diseases (1)
microplasmin (4) · Plasminogen (2)
Alcon Research (2) · ThromboGenics (2) · Jeffrey S Heier (1) · Northern California Retina Vitreous Associates (1) · Nova Southeastern University (1)
United States (5) · Australia (1) · Belgium (1) · Czechia (1) · Germany (1) · Poland (1) · Spain (1) · United Kingdom (1)
Alok S Bansal, MD (1) · Jeffrey S Heier, MD (1) · Julie A Rodman, OD, MS, FAAO (1)